Literature DB >> 20303955

The immunopathogenesis of Entamoeba histolytica.

Leanne Mortimer1, Kris Chadee.   

Abstract

Amebiasis is the disease caused by the enteric dwelling protozoan parasite Entamoeba histolytica. The WHO considers amebiasis as one of the major health problems in developing countries; it is surpassed by only malaria and schistosomiasis for death caused by parasitic infection. E. histolytica primarily lives in the colon as a harmless commensal, but is capable of causing devastating dysentery, colitis and liver abscess. What triggers the switch to a pathogenic phenotype and the onset of disease is unknown. We are becoming increasingly aware of the complexity of the host-parasite interaction. During chronic stages of amebiasis, the host develops an immune response that is incapable of eliminating tissue resident parasites, while the parasite actively immunosuppresses the host. However, most individuals with symptomatic infections succumb only to an episode of dysentery. Why most halt invasion and a minority progress to chronic disease remains poorly understood. This review presents a current understanding of the immune processes that shape the outcome of E. histolytica infections during its different stages. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303955     DOI: 10.1016/j.exppara.2010.03.005

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  66 in total

1.  Colocutaneous fistula secondary to amoebiasis.

Authors:  Owain P Jones; John A Murphy; Bushra N Hamid; Dale Vimalachandran
Journal:  Int J Surg Case Rep       Date:  2010-12-21

2.  The Entamoeba histolytica Dnmt2 homolog (Ehmeth) confers resistance to nitrosative stress.

Authors:  Rivi Hertz; Ayala Tovy; Michael Kirschenbaum; Meirav Geffen; Tomoyoshi Nozaki; Noam Adir; Serge Ankri
Journal:  Eukaryot Cell       Date:  2014-02-21

3.  Adaptive immune response in symptomatic and asymptomatic enteric protozoal infection: evidence for a determining role of parasite genetic heterogeneity in host immunity to human giardiasis.

Authors:  Zahra Babaei; Najmeh Malihi; Naser Zia-Ali; Iraj Sharifi; Mohammad A Mohammadi; Martin F Kagnoff; Lars Eckmann; Steven M Singer; Shahram Solaymani-Mohammadi
Journal:  Microbes Infect       Date:  2016-07-08       Impact factor: 2.700

Review 4.  The future for vaccine development against Entamoeba histolytica.

Authors:  Jeanie Quach; Joëlle St-Pierre; Kris Chadee
Journal:  Hum Vaccin Immunother       Date:  2014-02-06       Impact factor: 3.452

5.  Ubc7/Ube2g2 ortholog in Entamoeba histolytica: connection with the plasma membrane and phagocytosis.

Authors:  Rinki Kumari; Preeti Gupta; Swati Tiwari
Journal:  Parasitol Res       Date:  2018-03-28       Impact factor: 2.289

6.  The Potential of Lactobacillus casei and Entercoccus faecium Combination as a Preventive Probiotic Against Entamoeba.

Authors:  Nitya Sarjapuram; Niharika Mekala; Meetali Singh; Utpal Tatu
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

7.  Entamoeba histolytica Alters Ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency.

Authors:  Eduardo R Cobo; Ravi Holani; France Moreau; Kiminori Nakamura; Tokiyoshi Ayabe; Jennifer R Mastroianni; Yoshihiro Eriguchi; Andre Ouellette; Kris Chadee
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

8.  Gal-lectin-dependent contact activates the inflammasome by invasive Entamoeba histolytica.

Authors:  L Mortimer; F Moreau; S Cornick; K Chadee
Journal:  Mucosal Immunol       Date:  2013-11-20       Impact factor: 7.313

9.  Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing.

Authors:  Eduardo R Cobo; Chen He; Ken Hirata; Grace Hwang; UyenPhuong Tran; Lars Eckmann; Richard L Gallo; Sharon L Reed
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

10.  Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.

Authors:  Nicole M Mackey-Lawrence; Xiaoti Guo; Daniel E Sturdevant; Kimmo Virtaneva; Matthew M Hernandez; Eric Houpt; Alan Sher; Stephen F Porcella; William A Petri
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.